Wednesday, November 12, 2025

Wegovy and Ozempic tied to dramatically lower cancer deaths

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users. Researchers suspect the drugs’ anti-inflammatory and metabolic effects contribute to improved outcomes. They’re now calling for clinical trials to test whether these findings reflect a true anti-cancer mechanism.

from Top Health News -- ScienceDaily https://ift.tt/uK5WlGq

No comments:

Post a Comment

Why middle age is becoming a breaking point in the U.S.

A new international study finds that middle-aged Americans are lonelier, more depressed, and experiencing worse memory and health than earli...